RT Journal Article
SR Electronic
T1 Phylodynamics Of A Regional, Sars-Cov-2 Rapid Spreading Event In Colorado
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.28.21262976
DO 10.1101/2021.09.28.21262976
A1 Kristen J. Wade
A1 Samantha Tisa
A1 Chloe Barrington
A1 Kristy R. Crooks
A1 Chris R. Gignoux
A1 Austin T. Almand
A1 J. Jordan Steel
A1 John C. Sitko
A1 Joseph W. Rohrer
A1 Douglas P. Wickert
A1 Erin A. Almand
A1 David D. Pollock
A1 Olivia S. Rissland
YR 2021
UL http://medrxiv.org/content/early/2021/09/29/2021.09.28.21262976.abstract
AB Since the initial reported discovery of SARS-CoV-2 in late 2019, genomic surveillance has been an important tool to understand its transmission and evolution. Here, we describe a case study of genomic sequencing of Colorado SARS-CoV-2 samples collected August through November 2020 at the University of Colorado Anschutz Medical campus in Aurora and the United States Air Force Academy in Colorado Springs. We obtained nearly complete sequences for 44 genomes, inferred ancestral sequences shared among these local samples, and used NextStrain variant and clade frequency monitoring in North America to place the Colorado sequences into their continental context. Furthermore, we describe genomic monitoring of a lineage that likely originated in the local Colorado Springs community and expanded rapidly over the course of two months in an outbreak within the well-controlled environment of the United States Air Force Academy. This variant contained a number of amino acid-altering mutations that may have contributed to its spread, but it appears to have been controlled using extensive contact tracing and strict quarantine protocols. The genome sequencing allowed validation of the transmission pathways inferred by the United States Air Force Academy and provides a window into the evolutionary process and transmission dynamics of a potentially dangerous but ultimately contained variant.SIGNIFICANCE SARS-CoV-2 spreads and mutates, negatively impacting containment. In this study, we use long-read sequencing to generate 44 SARS-CoV-2 genomes from COVID-19 patients associated with a rapid-spreading event on the USAFA campus, as well as a neighboring community for reference. We reconstruct the genomic and evolutionary signatures of the rapid-spreading event, and pin-point novel, protein-altering mutations that may have impacted viral fitness. These insights into viral evolutionary dynamics, in the context of contact tracing and a rigorous containment program, help to inform response efforts in the future.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKW is supported by NIH R01 GM083127. CB is supported by the T32 grant T32GM136444 awarded to the Molecular Biology graduate program. This work was supported by NIH grants R35GM128680 (OSR) and the RNA Bioscience Initiative.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The United States Air Force Academy Institutional Review Board (IRB) determined the surveillance testing (FAC20200035E) was approved as Not Human Subjects Research in accordance with Title 32, Subtitle A, Chapter I, Subchapter M, Part 219: Protection of Human Subjects, Department of Defense Instruction 3216.02: Protection of Human Subjects and Adherence to Ethical Standards in Department of Defense Conducted and Supported Research and Air Force Instruction 40-402: Protection of Human Subjects in Biomedical and Behavioral Research. Use of the University of Colorado Biobank samples for this study was reviewed by the COVID-19 Biobanking Committee on May 20, 2020 and approved May 22, 2020 in letter communicated by Matthew J. Steinbeiss, Special Projects Manager, Office of Regulatory Compliance, University of Colorado Denver, Anschutz Medical Campus, and signed by Thomas Flaig, Vice Chancellor for Research, University of Colorado Denver, Anschutz Medical Campus. All samples were processed in the Rissland laboratory under IBC#1366. We were advised by Taylor Brumbelow (Human Research Protections, COMIRB Investigator Support, University of Colorado Denver, Anschutz Medical Campus, comirb{at}ucdenver.edu) on May 19, 2020, that our research qualifies as non-human subjects research because we did not have access to or use identifiers such as exact dates of service or admission, county, or zip code. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll sequenced SARS-CoV-2 genomes are available on GISAID EpiCoV database, accession numbers available upon request. Relevant analysis code is on Pollock lab Bitbucket and publicly accessible. https://bitbucket.org/pollocklaboratory/covid19phylodynamicscode2021/